Loading...
Market
Main Funding Source for First Large-Scale Human CRISPR Trial
5
Resolution / Starting Odds
Government • 33%
Private Sector • 33%
Public-Private Partnership • 34%
Financial disclosures or funding announcements related to CRISPR trials
Story
CRISPR Edits Genes in Fetal Monkeys, Advances Cure for Genetic Diseases
Apr 23, 2024, 01:51 PM
Recent advancements in CRISPR technology have brought the possibility of curing genetic diseases before birth closer to reality, with successful experiments conducted on fetal monkeys. Researchers achieved a scientific milestone by using CRISPR base editing to treat liver disease in these subjects. This breakthrough in genome editing has been recognized as a crucial step towards addressing genetic diseases as a significant public health challenge.
View original story
Similar markets
Government grants • 33%
Private foundations • 33%
Corporate sponsorships • 33%
Government grants • 33%
Private sector investment • 33%
Public-private partnerships • 34%
Cancer • 20%
Rare genetic disorders • 20%
Heart disease • 20%
Neurological disorders • 20%
Other • 20%
Government grant • 25%
Private foundation • 25%
University funding • 25%
Corporate sponsorship • 25%
NIH • 33%
Wellcome Trust • 33%
Private pharmaceutical companies • 33%
Other • 33%
